• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医生在开具抗抑郁药处方时提供的信息类型。

Types of information physicians provide when prescribing antidepressants.

作者信息

Young Henry N, Bell Robert A, Epstein Ronald M, Feldman Mitchell D, Kravitz Richard L

机构信息

Social and Administrative Sciences Division, School of Pharmacy, University of Wisconsin, Madison, WI, USA.

出版信息

J Gen Intern Med. 2006 Nov;21(11):1172-7. doi: 10.1111/j.1525-1497.2006.00589.x.

DOI:10.1111/j.1525-1497.2006.00589.x
PMID:17026727
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1831652/
Abstract

BACKGROUND

Providing antidepressant information to patients may foster greater adherence to therapy.

OBJECTIVE

To assess physician information-giving while prescribing antidepressants, and to identify factors that influence the provision of information.

DESIGN

Randomized experiment using standardized patients (SPs). Standardized patients roles were generated by crossing 2 clinical conditions (major depression or adjustment disorder) with 3 medication request types (brand-specific, general, or none).

PARTICIPANTS

One hundred and fifty-two general internists and family physicians recruited from solo and group practices and health maintenance organizations; cooperation rates ranged from 53% to 61%.

MEASUREMENTS

We assessed physician information-giving by analyzing audio-recordings of interactions between physicians and SPs, and collected physician background information by survey. Generalized estimating equations were used to examine the influence of patient and physician factors on physicians' provision of information.

RESULTS

One hundred and one physicians prescribed antidepressants, accounting for 131 interactions. The mean age of physicians was 46.3 years; 69% were males. Physicians mentioned an average of 5.7 specific topics of antidepressant-related information (of a possible maximum of 11). The most frequently mentioned topic was purpose (96.1%). Physicians infrequently provided information about the duration of therapy (34.9%) and costs (21.4%). Standardized patients who presented with major depression received less information than those with adjustment disorder, and older and solo/private practice physicians provided significantly less information to SPs.

CONCLUSIONS

Physicians provide limited information to patients while prescribing antidepressants, often omitting critical information that may promote adherence. Mechanisms are needed to ensure that patients receive pertinent antidepressant information.

摘要

背景

向患者提供抗抑郁药相关信息可能会提高其治疗依从性。

目的

评估医生在开具抗抑郁药时提供信息的情况,并确定影响信息提供的因素。

设计

使用标准化患者(SPs)进行随机试验。标准化患者的角色通过将2种临床病症(重度抑郁症或适应障碍)与3种药物请求类型(特定品牌、通用或无请求)交叉产生。

参与者

从个体和团体诊所以及健康维护组织招募的152名普通内科医生和家庭医生;合作率在53%至61%之间。

测量

我们通过分析医生与标准化患者之间互动的录音来评估医生提供信息的情况,并通过调查收集医生背景信息。使用广义估计方程来检验患者和医生因素对医生提供信息的影响。

结果

101名医生开具了抗抑郁药,共有131次互动。医生的平均年龄为46.3岁;69%为男性。医生平均提及5.7个抗抑郁药相关信息的具体主题(可能的最大主题数为11个)。最常提及的主题是目的(96.1%)。医生很少提供关于治疗持续时间(34.9%)和费用(21.4%)的信息。患有重度抑郁症的标准化患者比患有适应障碍的患者获得的信息更少,年龄较大以及个体/私人执业的医生向标准化患者提供的信息明显更少。

结论

医生在开具抗抑郁药时向患者提供的信息有限,常常遗漏可能促进依从性的关键信息。需要建立机制以确保患者获得相关的抗抑郁药信息。

相似文献

1
Types of information physicians provide when prescribing antidepressants.医生在开具抗抑郁药处方时提供的信息类型。
J Gen Intern Med. 2006 Nov;21(11):1172-7. doi: 10.1111/j.1525-1497.2006.00589.x.
2
Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial.患者对面向消费者宣传的抗抑郁药的需求影响:一项随机对照试验。
JAMA. 2005 Apr 27;293(16):1995-2002. doi: 10.1001/jama.293.16.1995.
3
Caught in the act? Prevalence, predictors, and consequences of physician detection of unannounced standardized patients.被当场抓住?医生发现未提前通知的标准化病人的患病率、预测因素及后果
Health Serv Res. 2006 Dec;41(6):2290-302. doi: 10.1111/j.1475-6773.2006.00560.x.
4
Do patient requests for antidepressants enhance or hinder physicians' evaluation of depression? A randomized controlled trial.患者对抗抑郁药的需求会增强还是阻碍医生对抑郁症的评估?一项随机对照试验。
Med Care. 2006 Dec;44(12):1107-13. doi: 10.1097/01.mlr.0000237202.96962.fd.
5
Exploring and validating patient concerns: relation to prescribing for depression.探索并验证患者的担忧:与抑郁症处方的关系。
Ann Fam Med. 2007 Jan-Feb;5(1):21-8. doi: 10.1370/afm.621.
6
Physician prescribing patterns of innovative antidepressants in the United States: the case of MDD patients 1993-2007.美国创新型抗抑郁药的医师处方模式:以 MDD 患者为例(1993-2007 年)。
Int J Psychiatry Med. 2011;42(4):353-68. doi: 10.2190/PM.42.4.b.
7
[Antidepressants consumption in the global population in France].[法国全球人口中的抗抑郁药消费情况]
Encephale. 2002 Sep-Oct;28(5 Pt 1):411-7.
8
Sexual dysfunction and physicians' perception in medicated patients with major depression in Taiwan.台湾地区服用药物治疗的重度抑郁症患者的性功能障碍及医生认知情况
Depress Anxiety. 2008;25(9):E56-62. doi: 10.1002/da.20312.
9
Physician alerts to increase antidepressant adherence: fax or fiction?医生提醒以提高抗抑郁药依从性:传真还是虚构?
Arch Intern Med. 2006 Mar 13;166(5):498-504. doi: 10.1001/archinte.166.5.498.
10
Antidepressant use in older people: family physicians' knowledge, attitudes, and practices.老年人使用抗抑郁药:家庭医生的知识、态度和做法。
Can Fam Physician. 2005 Jan;51(1):80-1.

引用本文的文献

1
Exploring mental health clients' current medication knowledge, beliefs and experience with healthcare providers in the community in South Australia.探索南澳大利亚社区中精神健康客户当前的药物知识、信念以及与医疗保健提供者的经验。
Health Soc Care Community. 2022 Nov;30(6):e5968-e5978. doi: 10.1111/hsc.14029. Epub 2022 Sep 23.
2
Experiences of the Medication Use Process by People with Intellectual Disabilities. What a Pharmacist Should Know!智障人士用药过程的经验。药剂师应该了解什么!
Pharmacy (Basel). 2021 Jan 21;9(1):24. doi: 10.3390/pharmacy9010024.
3
Recommendations for Providers on Person-Centered Approaches to Assess and Improve Medication Adherence.给医疗服务提供者的关于以患者为中心的评估和改善药物依从性方法的建议。
J Gen Intern Med. 2017 Jan;32(1):93-100. doi: 10.1007/s11606-016-3851-7.
4
Gist and verbatim communication concerning medication risks/benefits.关于药物风险/益处的要点及逐字交流。
Patient Educ Couns. 2016 Jun;99(6):988-94. doi: 10.1016/j.pec.2015.12.001. Epub 2015 Dec 29.
5
Understanding the non-pharmacological correlates of self-reported efficacy of antidepressants.了解抗抑郁药自我报告疗效的非药物相关因素。
Acta Psychiatr Scand. 2015 Jun;131(6):434-45. doi: 10.1111/acps.12390. Epub 2015 Jan 9.
6
Barriers to medication counselling for people with mental health disorders: a six country study.精神健康障碍患者药物咨询的障碍:一项六国研究。
Pharm Pract (Granada). 2010 Apr;8(2):122-31. doi: 10.4321/s1886-36552010000200007. Epub 2010 Mar 15.
7
Communicating Numerical Risk: Human Factors That Aid Understanding in Health Care.传达数值风险:有助于医疗保健理解的人为因素。
Rev Hum Factors Ergon. 2013 Oct;8(1):235-276. doi: 10.1177/1557234X13492980.
8
Communication about ADHD and its treatment during pediatric asthma visits.在儿科哮喘就诊期间交流 ADHD 及其治疗。
Community Ment Health J. 2014 Feb;50(2):185-92. doi: 10.1007/s10597-013-9678-3. Epub 2013 Dec 24.
9
Adherence to antidepressant medications: an evaluation of community pharmacists' counseling practices.抗抑郁药物的依从性:社区药剂师咨询实践的评估
Patient Prefer Adherence. 2013 Aug 21;7:813-25. doi: 10.2147/PPA.S48486. eCollection 2013.
10
Child and caregiver reported problems in using asthma medications and question-asking during paediatric asthma visits.儿童和照顾者报告了在儿科哮喘就诊期间使用哮喘药物和提问方面存在的问题。
Int J Pharm Pract. 2014 Feb;22(1):69-75. doi: 10.1111/ijpp.12043. Epub 2013 May 29.

本文引用的文献

1
Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial.患者对面向消费者宣传的抗抑郁药的需求影响:一项随机对照试验。
JAMA. 2005 Apr 27;293(16):1995-2002. doi: 10.1001/jama.293.16.1995.
2
Do the incentives in 3-tier pharmaceutical benefit plans operate as intended? Results from a physician leadership survey.三层药品福利计划中的激励措施是否按预期运作?一项医生领导力调查的结果。
Am J Manag Care. 2005 Jan;11(1):16-22.
3
Hispanic ethnicity, language, and depression: physician-patient communication and patient use of alternative treatments.西班牙裔种族、语言与抑郁症:医患沟通及患者对替代疗法的使用
Int J Psychiatry Med. 2004;34(3):235-46. doi: 10.2190/VQU1-QYWT-XW6Y-4M14.
4
Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression.药物推广对抑郁症治疗指南依从性的影响。
Med Care. 2004 Dec;42(12):1176-85. doi: 10.1097/00005650-200412000-00004.
5
Executive functions and updating of the contents of working memory in unipolar depression.单相抑郁症中的执行功能与工作记忆内容的更新
J Psychiatr Res. 2004 Nov-Dec;38(6):567-76. doi: 10.1016/j.jpsychires.2004.03.003.
6
Strategies to improve medication adherence in patients with depression.
Am J Health Syst Pharm. 2003 Dec 15;60(24):2601-5. doi: 10.1093/ajhp/60.24.2601.
7
Improving adherence to antidepressants: a systematic review of interventions.提高抗抑郁药的依从性:干预措施的系统评价
J Clin Psychiatry. 2003 Dec;64(12):1415-20. doi: 10.4088/jcp.v64n1203.
8
Improving antidepressant adherence.提高抗抑郁药的依从性。
J Clin Psychiatry. 2003;64 Suppl 18:25-30.
9
Patient-physician communication about out-of-pocket costs.医患之间关于自付费用的沟通。
JAMA. 2003 Aug 20;290(7):953-8. doi: 10.1001/jama.290.7.953.
10
The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).重度抑郁症的流行病学:全国共病调查复制研究(NCS-R)结果
JAMA. 2003 Jun 18;289(23):3095-105. doi: 10.1001/jama.289.23.3095.